SCHEMBL22403096

SCHEMBL22403096

CC(C)(C)n1cccc1C(N)=O

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 3/20 0.41
ALDH1A1 P00352 3/20 0.41
MAP3K14 Q99558 1/20 0.40
KDM4E B2RXH2 2/20 0.38
MAPT P10636 4/20 0.35
KMT2A Q03164 2/20 0.35
POLB P06746 2/20 0.33
TDP1 Q9NUW8 2/20 0.33
L3MBTL1 Q9Y468 2/20 0.33
APEX1 P27695 1/20 0.33
NPC1 O15118 2/20 0.33
RAB9A P51151 2/20 0.33
MEN1 O00255 1/20 0.33
NPSR1 Q6W5P4 1/20 0.33
PARP1 P09874 2/20 0.32
CYP3A4 P08684 1/20 0.32
TSHR P16473 1/20 0.32
CYP2C19 P33261 1/20 0.32
RECQL P46063 1/20 0.32
BLM P54132 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13539048 0.82 BAZ2B (0.35) LMNAALDH1A1KMT2APOLBTDP1
SCHEMBL3520677 0.82 POLB (0.46) LMNAALDH1A1KDM4EMAPTKMT2A
SCHEMBL3163920 0.80 LMNA (0.40) LMNAALDH1A1MAP3K14KDM4EMAPT
SCHEMBL308631 0.72
SCHEMBL1269750 0.70
SCHEMBL4427821 0.69 LMNA (0.53) LMNAALDH1A1MAP3K14KDM4EMAPT
SCHEMBL30034979 0.69 NOTUM (0.41) LMNAMAP3K14KDM4EMAPTPOLB
SCHEMBL5653476 0.68 LMNA (0.43) LMNAALDH1A1MAP3K14KDM4EMAPT
SCHEMBL18193495 0.68
Hydrochloric Acid SCHEMBL28339228 0.68 LMNA (0.43) LMNAALDH1A1MAP3K14KDM4EMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11786575-B2 Endoparasitic depsipeptides ZOETIS SERVICES LLC (US) 2023-10-17 US disclosed
US-20220211802-A1 Endoparasitic Depsipeptides ZOETIS SERVICES LLC 2022-07-07 US disclosed
US-11331369-B2 Endoparasitic depsipeptides ZOETIS SERVICES LLC (US) 2022-05-17 US disclosed
US-20200282016-A1 Endoparasitic Depsipeptides ZOETIS SERVICES LLC 2020-09-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11786575-B2 Endoparasitic depsipeptides VIP, PREP, NGLY1 LMNA 1682/4885ALDH1A1 3102/4885MAP3K14 4003/4885
US-20200282016-A1 Endoparasitic Depsipeptides VIP, PREP, NGLY1 LMNA 1682/4885ALDH1A1 3102/4885MAP3K14 4003/4885
US-20220211802-A1 Endoparasitic Depsipeptides VIP, PREP, NGLY1 LMNA 1682/4885ALDH1A1 3102/4885MAP3K14 4003/4885
US-11331369-B2 Endoparasitic depsipeptides VIP, PREP, NGLY1 LMNA 1682/4885ALDH1A1 3102/4885MAP3K14 4003/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.